Zobrazeno 1 - 8
of 8
pro vyhledávání: '"D C, Longee"'
Publikováno v:
Journal of neuro-oncology. 46(2)
Cyclophosphamide is an alkylating agent that has shown activity in the treatment of pediatric brain tumors, including high-grade gliomas. This study was designed to evaluate the response of patients with newly diagnosed glioblastoma multiforme to pre
Publikováno v:
Clinical neuropathology. 18(4)
We describe the case of a 7-year-old girl who was clinically diagnosed as having a pontine glioma based on magnetic resonance imaging studies. Neoplastic cells were identified upon cytologic examination of cerebrospinal fluid. Autopsy studies reveale
Publikováno v:
Archives of pathologylaboratory medicine. 123(4)
From both epidemiologic and pathologic viewpoints, gangliogliomas exhibiting components of giant cell glioblastomas are extraordinary neoplasms. We report herein the case of a 6-year-old girl who presented initially with a World Health Organization g
Autor:
G B, McCowage, H S, Friedman, A, Moghrabi, T, Kerby, L, Ferrell, E, Stewart, M, Duncan-Brown, H E, Fuchs, R, Tien, R E, McLendon, L, Meier, J, Kurtzberg, D, Ashley, O M, Colvin, D C, Longee
Publikováno v:
Medical and pediatric oncology. 30(2)
Seventeen patients less than or equal to 20 years of age with newly diagnosed (n = 10) or recurrent (n = 7) malignant gliomas (anaplastic astrocytoma and glioblastoma multiforme) were treated with cyclophosphamide in association with hematopoietic cy
Autor:
C J, Wikstrand, D C, Longee, R E, McLendon, G N, Fuller, H S, Friedman, P, Fredman, L, Svennerholm, D D, Bigner
Publikováno v:
Cancer research. 53(1)
Two monoclonal antibodies, DMAb-21 and DMAb-22, directed against the lactotetraose series ganglioside-associated epitope IV3NeuAc,III6-NeuAcLcOse4Cer (3',6'-isoLD1), were found to define the minimum binding epitope NeuAc(or NeuGc)alpha 2-3Gal beta 1-
Autor:
Jan-Eric Månsson, Carol J. Wikstrand, Sandra H. Bigner, D. C. Longee, Pam Fredman, Gregory N. Fuller, Lars Svennerholm, Xuanmin He, Darell D. Bigner
Publikováno v:
Journal of Neuropathology and Experimental Neurology. 49:320
Publikováno v:
Antimicrobial Agents and Chemotherapy. 29:670-674
Cerebrospinal fluid (CSF) penetration of imipenem-cilastatin was evaluated in 20 children (aged 4 months to 11 years) with central nervous system infections. A total of 10 children received a single 25-mg/kg intravenous dose, and 10 received three 25
Publikováno v:
Neurosurgery. 23:248